ABOUT

DR. SHARIFI

Dr Sharifi is Director of Arizona Cardiovascular Consultants & Vein Clinic. He is an Adjunct Professor at A.T.Still University in Mesa, Arizona. Dr. Sharifi is Board Certified in Interventional Cardiology, Cardiovascular Diseases, Vascular Medicine, Internal Medicine and Nuclear Cardiology.

He completed his Interventional Cardiology Fellowship at Indiana University School of Medicine in 1999 and was on Faculty at Case Western Reserve University and Texas Tech University.

Dr. Sharifi is Faculty at American College of Cardiology, Society for Cardiovascular Interventions, Trans Catheter Therapeutics, New Cardiovascular Horizons and many other societies. His research interest is in the treatment of venous thromboembolism. Dr. Sharifi has authored numerous papers and lectured extensively in national and international scientific meetings on this topic.

Dr. Sharifi is fluent in English, Farsi and Spanish

Our Vision:

Our vision is to provide unparalleled and highest quality of cardiovascular and venous care to our patients. We strive to integrate the most advanced and clinically proven medical technology in our services. We view our patients not as a “case” but as individuals who need to be treated as a “whole” taking into consideration interactions of heart, body and mind. Through our ongoing clinical research, we utilize and apply advanced therapies in our clinical practice.

Our Practice:

We believe that through a small yet highly effective practice, our patients can be far better serviced as opposed to the service rendered by a large group. In our practice, a one-to one professional relationship exists which is essential for patient satisfaction. When you call our office you speak with a live person rather than a machine. Your questions will be answered the same day. Our staff makes every effort to accommodate patient requests and arrange for appointments in the shortest possible time. There are no interruptions of our services for lunch or other breaks.

Our Location:

We are located in the most desirable location in the East Valley. We are housed in a 7200 sq feet modern facility on Baseline Road and 39th Street with frontage view on Baseline Road. Our office is a walking distance from Dana Park where a variety of amenities are available. It is conveniently located a short distance from Highway US 60.

Chapters / Publications / Abstracts

Book Chapters

Journal Publications

Sharifi M. Systemic full dose, half dose and catheter directed thrombolysis for pulmonary embolism. When to use and how to choose? Curr Treat Options Cardio Med 18:31 Feb. 2016.

Sharifi M, Berger J, Beeston P et al. Pulseless Electrical Activity in Pulmonary Embolism Treated with Thrombolysis, (From the “PEAPETT” Study). Am J Emerg Med Epub June 30, 2016.

Sharifi M, Vajo Z , Freeman W et al. Transforming and Simplifying the Treatment of Pulmonary Embolism: “Safe Dose” Thrombolysis Plus New Oral Anticoagulants. LUNG 193:369-74 2015.

Sharifi M. Optimal Treatment of Submassive Pulmonary Embolism. http://www.acc.org. September 15, 2015.

Sharifi M, Bay C, Vajo Z. et al. New Oral Anticoagulants in the Treatment of Heparin- Induced Thrombocytopenia. Thrombosis Research 2015 Apr;135(4):607-9

Sharifi M, Freeman W, Bay C, et al. Low Incidence of Post-Thrombotic Syndrome in Patients Treated with New Oral Anticoagulants and Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis. Vasc Med April 2015.

Sharifi M, Bay C, Schwartz F, Skrocki L. “Safe Dose Thrombolysis” plus Rivaroxaban in the Treatment of Moderate and Severe Pulmonary Embolism: “Drip, Drug, and Discharge”.
Clinical Cardiology 37; 78-82,2014.

Sharifi M. Modern Management of Acute Deep Venous Thrombosis.
Vasc Dis Mgmt Vasc Dis Mgmt 11: E2-E11; 2014.

Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate Pulmonary Embolism Treated with Thrombolysis: The “MOPETT” Trial.
Am J Cardiol 111: 273- 277, 2013.

Sharifi M Naming the Magnitude of the Final Pulmonary Artery Systolic Pressure is in the Eye of the Beholder. Author’s Reply.
Am J Cardiol 111:1831, 2013 .

Sharifi M, Bay C, Nowroozi S, Bentz S, Valeros G, Catheter Directed Thrombolysis with Argatroban and tPA for Extensive Iliac and Femoropopliteal Vein Thrombosis.
Cardiovasc Interv Rad 36: 1586-159, 2013.

Sharifi M, Bay C, Mehdipour M, Sharifi J.Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial: Mid-term Results.
J Endovas Therapy 19:273–280, 2012.

Sharifi M, Bay C, Skrocki L, Lawson D, Mazdeh S. Role of IVC Filters in Endovenous Therapy for Deep Venous Thrombosis: The FILTER-PEVI Trial.
Cardiovasc Interv Rad 35:1408–1413, 2012.

Sharifi M, Javadpour S, Bay C, Mehdipour M, Emrani F, Sharifi J. Outcome of Stenting in the Lower Extremity Venous Circulation for the Treatment of Deep Venous Thrombosis.
Vasc Dis Mgmt 7: 233-239, 2010

Sharifi M, Mehdipour M, Bay C, Emrani F, Sharifi J. Effect of anticoagulation on endothermal ablation of the great saphenous vein.
J Vasc Surg 53: 147-149 2011.

Sharifi M, Mehdipour M, Bay C, Smith G, Sharifi J. Endovenous Therapy for Deep Venous Thrombosis : The TORPEDO Trial.
Catheteriz Cardiovasc Interv 2010; 76:316-325

Sharifi M,, Mehdipour M. Percutaneous Therapy of Acute on Chronic Lower Extremity Venous Occlusive Disease.
Catheteriz Cardiovasc Interv 75:685-689,2010.

Sharifi M, Mehdipour M, Skloven D, et al. Power Pulse Spray and Angiojet Thrombectomy in Massive Inferior Vena Cava and Bilateral Lower Extremity Deep Venous Thrombosis.
Vasc Dis Mgmt 5:62-65,2008.

Sharifi M, Parhizgar A, Gupta P, Mehdipour M. et al. Is Transesophageal Echocardiography Necessary before D.C. Cardioversion in Patients with a Normal Transthoracic Echocardiogram?
Echocardiography 24:397-400, 2007.

Sharifi M, Parhizgar A, Mehdipour M et al. Percutaneous Balloon Aortic Valvuloplasty: A new look at an old procedure.
Angiology 57:724-728, 2007.

Sharifi M, Dehghani M, Mehdipour M, Al-Bustami O, Burks J. Intense migraines secondary to percutaneous closure of atrial septal defects.
J Interv Cardiol 18:181-183, 2005.

Sharifi M, Fares W, Abdel-Karim I et al. The Usefulness of Hyperbaric Oxygen Therapy to Inhibit Restenosis in Percutaneous Coronary Interventions after Acute Myocardial Infarction and Unstable Angina Pectoris.
Am J Cardiol 93:1533-1535, 2004.

Sharifi M, Burks J. Efficacy of Clopidogrel in the Treatment of Post-ASD Closure Migraines.
Catheteriz Cardiovascular Interven 2004, 63:255.

Sharifi M, Inbar S, Neckels , Shook H. Twiddling to the extreme: Development of Twiddler syndrome in an ICD.
J Invasive Cardiol 17: Feb 2005.

Bustami O, Sharifi M, Hijazi Z Necessity for evaluation of partial anomalous pulmonary venous return prior to percutaneous closure of interatrial shunts in adults.
Angiology 56:647-650, 2005.

Bourdillon P, Von der Lohe E, Lewis SJ, Sharifi M, et al. Comparison of Left Ventriculography and Coronary Arteriography with Positron Emission Tomography in Assessment of Myocardial Viability.
Clin Cardiol 26:60-66,2003.

Fares W, Sharifi M, Sawaf N, et al. Superior Vena Cava Syndrome Secondary to Saphenous Vein Graft Aneurysm with Right Atrial Fistula.
Catheter Cardiovascular Interventions 60:45-47,2003.

Sharifi M, Fares W, Abdel-Karim I et al. Inhibition of Restenosis by Hyperbaric Oxygen: A Novel Indication for an old Modality.
Cardovasc Rad Med.3:124-126,2003

Sharifi M, Koch JM, Steele RJ et al. Third Degree AV Block Due to Ophthalmic Timolol Solution.
Internat J Cardiol 80: 257-259, 2001.

Sharifi M, Koch M , Steele R et al. Pace but with Grace.
Catheteriz Cardiovascular Interven 52: 535,2001.

Sharifi M, Siraj Y, O’Donnell J et al. Coronary Angioplasty and Stenting in Orthotopic Heart Transplants: A Fruitful Act or a Futile Attempt?
Angiology 51: 809-815, 2000.

Sharifi M, Dillon JC, Pompili VJ. Saphenous Vein Graft Ectasia.An Unusual Complication of Coronary Artery Bypass Surgery.
Angiology 50: 497-501, 1999.

Sharifi M. Turrentine MW, Mahomed Y et al. Left Internal Mammary Artery Graft Perforation Secondary to High Pressure Stent Deployment. Catheteriz Cardiovascular Interven 47: 199 – 202, 1999.

Sharifi M, Lauer J, Pompili V, Dillon J. Arteriography of the left internal mammary artery graft using a balloon tipped floatation catheter: An alternative approach.
J Invasive Cardiol 11:682-684, 1999.

Sharifi M, Pompili VJ, Dillon JC. Manual Assembly of a Retrieval System for Retained Objects in the Coronary Circulation.
Internat J Cardiol 71: 85-86,1999.

Sharifi M, Murdock DK, Engelmeier RS et al. Simultaneous Presence of a Large Coronary Artery Aneurysm and Ectasia in a Young Patient With Myocardial Infarction.
Angiology 48: 1001 – 1005, 1997.

Sharifi M, Khedkar N, Peller P et al. First Pass Tc-99 M Mibi Ventriculography in the assessment of left ventricular diastolic function -A Comparison With Doppler Echocardiography.
Clin Nuc Med 21: 679 – 684,1996.

Sharifi M, Sorkin R, Lakier JB. Left Ventricular Pacing: A Fact, Not an Artifact.
Am J Cardiol(letter) P.379,1996.

Sharifi M, Messersmith R, Newman B et al. Bronchial Arteriovenous Malformation in a Child with Hemoptysis.
Angiology 47: 203 – 209, 1996.

Sharifi M, Sorkin R, Lakier J. Inadvertent Malposition of Transvenous Inserted Pacing Leads in the Left Ventricular Chamber.
Am J Cardiol 76: 92 – 95, 1995.

Sharifi M, Frohlich TG, Silverman IM. Myocardial Infarction With Angiographically Normal Coronary Arteries.
Chest 107: 36 – 44, 1995.

Sharifi M, Sorkin R, Lakier J. Left Heart Pacing and Cardioembolic Stroke.
PACE 17: 1691 – 1696, 1994.

Sharifi M, Sorkin R, Lakier J. Intraaortic Thrombosis as a Cause of Bowel Ischemia.
Angiology 45: 973 – 977,1994.

Sharifi M. Digoxin Induced Abdominal Pain in a Patient Undergoing Maintenance Hemodialysis.
Am J Nephrol 11: 409 – 10, 1991.

Abstracts

Sharifi M, Davies M Freeman W, et al. Role Of Wallstents In The Treatment Of Chronic Inferior Vena Cava Filter Occlusion J Am Coll Cardiol. 2015;66;15S.

Sharifi M, Berger J, Davies M, et al. Treatment of Massive Pulmonary Embolism During Cardio- Pulmonary Collapse and Pulseless Electrical Activity With Low Dose Systemic Thrombolysis. Vascular Medicine. 2016, Vol. 21(3), 305-306.

Sharifi M, Baqdunes W, Berger J, et al. Abdominal Aortic Endoluminal Grafts and Subsequent Abdominal Surgery Promotes Extensive Deep Vein Thrombosis. Catheterization and Cardiovascular Interventions. Supplmt, 87: S 45, April 2016.

Sharifi M, Baqdunes W, Berger J, et al. Outcome of Life Star Stents in the Venous Circulation .Catheterization and Cardiovascular Interventions. Supplmt, 87: S 46, April 2016.

Sharifi M, Ostrue J, Carey E, Freeman W. Role of New Oral Anticoagulants in the Treatment of Superficial Venous Thrombosis of the Lower Extremities. Vascular Medicine. 2014, Vol. 19(3).

Sharifi M, Freeman W, Davies M et al. Treatment of IVC Filter Chronic Occlusions with Wall Stents. Catheterization and Cardiovascular Interventions. 85: S 52, May 2015.

Sharifi M, Freeman W, Jiminez J et al. Role of Apixaban in Dialysis Patients after PEVI for DVT of Lower Extremities.Vasc Med 20:299; 2015.

Sharifi M, Freeman W, Bay C et al. Percutaneous Endovenous Intervention Plus New Oral Anticoagulants in Cancer Patients with Lower Extremity Deep venous Thrombosis. JACC March 17, 2015 A 523, 1258-333

Sharifi M, Freeman W, Bay C, Sharifi M, Breed C, Schwartz F. Treatment of Heparin Induced Thrombocytopenia with New Oral Anticoagulants. J Am Coll Cardiol. 2014; 63(12_S).

Sharifi M, Freeman W, Bay C, Sharifi M, Breed C, Schwartz F. Paradigm Shift in the Treatment of Pulmonary Embolism: Safe Dose Thrombolysis Plus Rivaroxaban. J Am Coll Cardiol. 2014; 63(12_S):. doi:10.1016/S0735-1097(14)61476-5

Sharifi M, Freeman W, Bay C, Sharifi M, Schwartz F. Percutaneous Endovenous Intervention and New Oral Anticoagulants Reduce Post-Thrombotic Syndrome in Acute Deep Venous Thrombosis. Catheterization and Cardiovascular Interventions. May 2014.Volume 83.Issue Supplement S1 (S64-65). doi:10.1002/ccd.

Sharifi M, Carey E, Mafi N, Freeman W, Sharifi M. Limited Role of Thrombectomy Devices Alone for Occlusive IVC Filter Thrombosis. Catheterization and Cardiovascular Interventions. May 2014.Vol.83.Issue Supplement S1 (S80-81).

Sharifi M, Ostrue J, Carey E, Freeman W. Role of New Oral Anticoagulants in the Treatment of Superficial Venous Thrombosis of the Lower Extremities. Vascular Medicine. 2014, Vol. 19(3). doi:10.1177/1358863X14533477

Sharifi M, Freeman W, Camiliere T, Vajo Z, Bay C, Sharifi M, Schwartz F. New Oral Anticoagulants in Cancer Patients Undergoing Percutaneous Endovenous Intervention for Lower Extremity Deep Venous Thrombosis. J Am Coll Cardiol. 2014; 64(11_S):. doi:10.1016/j.jacc.2014.07.532.

Sharifi M, Freeman W, Emami T, Chatham J, Schwartz F. Reduction of Hospitalization and Duration of Anticoagulation for Deep Venous Thrombosis in Patients Undergoing Percutaneous Endovenous Intervention and Receiving Novel Anticoagulants. J Am Coll Cardiol. 2013; 62(18_S1):B157-B157. doi:10.1016/j.jacc.2013.08.1263

Sharifi M, Freeman W, Chatham J, Emami T, Bay C, Schwartz F. Argatroban and t-PA During Catheter-Directed thrombolysis for Extensive lower Extremity Deep Venous Thrombosis. J Am Coll Cardiol. 2013; 62(18_S1):B157-B157. doi:10.1016/j.jacc.2013.08.1262

Sharifi M, Klyn S, Carroll K, et al. Treatment of Occlusive IVC Filter Thrombosis by Percutaneous Endovenous Intervention.
Catheteriz Cardiovasc Interv Supplement 1, 81:S 67-8;2013.